Our Mission

Suono Bio is a on a mission to harness its proprietary therapeutic platform to transform treatment of difficult-to-treat diseases by enabling localized delivery of small molecules, biologics, nucleic acids, and gene therapies without need for encapsulation. This novel approach has the potential to treat and/or cure many diseases with superior effectiveness, ultimately revolutionizing the clinical use of novel therapeutics altogether.

Meet the Team

Founders

Robert Langer, ScD
Co-​Founder

Gio Traverso, MD, PHD
Co-Founder

Carl Schoellhammer, PhD
Co-Founder, CTO

Management​

Scott Kellogg, MS, MBA
CEO

Sean Moran, CPA
Senior Management Advisor

Albert "Skip" Farinha
COO

Molly Dunham-Friel, MPH
Patient Advocacy Advisor

Carl Schoellhammer, PhD
Co-Founder, CTO

Harry Martins
VP, Engineering and New
Product Development

Tuan Elstrom
Senior New Business
​Development Lead

Board of Directors

Fred Shane
Managing Partner, Axil Capital

Robert Langer, ScD
Co-​Founder, Suono Bio

Gio Traverso, MD, PHD
Co-Founder, Suono Bio

Carl Schoellhammer, PhD
Co-Founder, CTO, Suono Bio

Scott Kellogg, MS, MBA
CEO, Suono Bio

Victoria Wang
Investment Principal
​Taiwania Capital

Medical Advisory Board

Kenolisa Onwueme, MD, PhD
Chair, Division of Gastroenterology
University of Maryland-Baltimore Washington Medical Center

Jakob Begun, MD, PhD
Director of Gastroenterology,
​Mater Hospital Brisbane

Scott Snapper
Chief, Division of Gastroenterology, Hepatology, and Nutrition
Boston Children's Hospital

David Feigal, MD
Partner, NDA Partners